4.5 Article

Evaluation of antioxidant and anticancer activity of crude extract and different fractions of Chlorella vulgaris axenic culture grown under various concentrations of copper ions

Journal

BMC COMPLEMENTARY MEDICINE AND THERAPIES
Volume 21, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12906-020-03194-x

Keywords

Chlorella vulgaris; Antioxidant and anticancer activity; Growth rate; Active ingredients

Funding

  1. Faculty of science and Faculty of Agriculture, Cairo University, Giza, Egypt

Ask authors/readers for more resources

This study investigates the antioxidant and prooxidant effect of Chlorella vulgaris cultivated under various concentrations of copper ions and identifies a compound with high antioxidant and anticancer activity. The compound showed potent effects against DPPH radical assay and Hela cancer cell line, suggesting potential pharmaceutical applications.
Background Chlorella vulgaris is a microalga potentially used for pharmaceutical, animal feed, food supplement, aquaculture and cosmetics. The current study aims to study the antioxidant and prooxidant effect of Chlorella vulgaris cultivated under various conc. of copper ions. Methods The axenic green microalgal culture of Chlorella vulgaris was subjected to copper stress conditions (0.00, 0.079, 0.158, 0.316 and 0.632 mg/L). The growth rate was measured at OD680 nm and by dry weight (DW). Moreover, the Antioxidant activity against DPPH and ABTS radical, pigments and phytochemical compounds of the crude extracts (methylene chloride: Methanol, 1:1) were evaluated. The promising Cu crude extract (0.316 mg/L) further fractionated into twenty-one fractions by silica gel column chromatography using hexane, chloroform and ethyl acetate as a mobile phase. Results The obtained results reported that nine out of these fractions exhibited more than 50% antioxidant activity and anticancer activity against Hela cancer cell lines. Based on IC50, fraction No. 7 was found to be the most effective fraction possessing a significant increase in both antioxidant and anticancer potency. Separation of active compound (s) in fraction No 7 was performed using precoated silica gel plates (TLC F-254) with ethyl acetate: hexane (9:1 v/v) as mobile phase. Confirmation of active compound separation was achieved by two-dimensional TLC and visualization of the separated compound by UV lamp. The complete identification of the separated active compound was performed by UV- Vis- spectrophotometric absorption, IR, MS, H-1-NMRT C-13-NMR. The isolated compound ((2E,7R,11R)-3,7,11,15-Tetramethyl-2-hexadecenol) have high antioxidant activity with IC50 (10.59 mu g/ml) against DPPH radical assay and comparable to the capacities of the positive controls, Butylated hydroxy toluene [BHT] (IC50 11.2 mu g/ml) and Vitamin C (IC50 12.9 mu g/ml). Furthermore, pure isolated compound exhibited a potent anticancer activity against Hela cell line with IC50 (4.38 mu g/ml) compared to Doxorubicin (DOX) as synthetic drug (13.3 mu g/ml). In addition, the interaction of the pure compound with Hela cancer cell line and gene expression were evaluated. Conclusions The authors recommend cultivation of Chlorella vulgaris in large scale under various stress conditions for use the crude extracts and semi purified fractions for making a pharmaco-economic value in Egypt and other countries.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available